Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

The new drug delivery system effectively targets lung cancer cells.

The treatment combination is effective and generally safe for lung cancer.

Clotrimazole, miconazole, and tolnaftate are likely safe, but gentian violet is risky.

Silver nanoparticles from Laurus nobilis leaves may be a new, safer antiarthritic treatment.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Onabotulinum toxin A may help treat trichotillomania and promote hair growth.

Baricitinib is effective as a treatment for severe hair loss.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

The herbal combination of saw palmetto and stinging nettle reduces nighttime urination in men with urinary issues.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

The combination treatment showed a higher response rate but no significant survival benefits.

The new treatment using tiny lipid carriers to deliver minoxidil and latanoprost directly to hair follicles shows promise for alopecia.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tumescent local anesthesia is a safe, cost-effective method for outpatient liposuction.

Nilotinib may cause gray hair to return to its original color.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

Ritlecitinib can help about 14,000 people with severe hair loss.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

A young man had rare serious side effects from an epilepsy drug, leading to stopping the drug.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Preservative-free latanoprost effectively lowers eye pressure with fewer side effects.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.